Sanz Solutions Health and Longevity

Since 2021, we have been creating, curating, and sharing free and transparent; health, nutrition, movement, and longevity information.

Daily Thoughts

View all
  • A New Frontier in Reducing Dementia Risk

    A New Frontier in Reducing Dementia Risk

    Derek Sanz

    In recent years, SGLT2 inhibitors have emerged as a transformative class of medications in the management of type 2 diabetes, offering significant benefits beyond just glycemic control. Among these, emerging...

    A New Frontier in Reducing Dementia Risk

    Derek Sanz

    In recent years, SGLT2 inhibitors have emerged as a transformative class of medications in the management of type 2 diabetes, offering significant benefits beyond just glycemic control. Among these, emerging...

  • Breakthrough in NASH Treatment: FDA Approves Rezdiffra

    Breakthrough in NASH Treatment: FDA Approves Re...

    Derek Sanz

    Breakthrough in NASH Treatment: FDA Approves Rezdiffra The FDA has recently approved Rezdiffra, a groundbreaking new drug for the treatment of non-alcoholic steatohepatitis (NASH), offering new hope to millions of...

    Breakthrough in NASH Treatment: FDA Approves Re...

    Derek Sanz

    Breakthrough in NASH Treatment: FDA Approves Rezdiffra The FDA has recently approved Rezdiffra, a groundbreaking new drug for the treatment of non-alcoholic steatohepatitis (NASH), offering new hope to millions of...

1 2
View all

Featured collection

View all